Introduction {#sec1-1}
============

After a decade of steady decline, syphilis has reemerged within the past few years and it is seeping back into the HIV negative population.^[@ref1]^ The fluctuation on its incidence around the world has raised the concern about the central nervous system invasion.^[@ref2]^ Unfortunately, the clinical and laboratory diagnosis of neurosyphilis is complex. Early invasion of the central nervous system (CNS) by *Treponema pallidum*, the causative agent of syphilis, is thought to occur in most patients within days after exposure. Typical neurological manifestations include acute meningeal syphilis, meningovascular syphilis, paretic neurosyphilis, and tabetic neurosyphilis.^[@ref1]-[@ref3]^

The diagnosis of neurosyphilis based on ocular findings is often elusive because of the various presentations. Ocular syphilis is considered an uncommon manifestation of syphilis. However, it can be the only manifestation in patients with neurological involvement.^[@ref1],[@ref3],[@ref4]^ The most common ocular manifestation is uveitis, but a multitude of other presenting signs have been described in both human immunodeficiency virus (HIV)-positive and HIV-negative patients.

Most of the large series of neurosyphilis were reported in the pre-penicillin era, when serological tests and therapy differed, hindering the extrapolation of some results.^[@ref3]^ The majority of new cases around the world are reported in HIV-infected patients, but the epidemiology of modern neurosyphilis is not well defined because of the paucity of populationbased data.^[@ref3]^ We aim to report the clinical manifestations and laboratory data of 16 (4 non-HIV) cases of neurosyphilis.

Materials and Methods {#sec1-2}
=====================

We reviewed all the medical records of the patients with the diagnosis of syphilis or neurosyphilis from 1989 to 2010.^[@ref1]-[@ref9]^ Neurosyphilis was defined as a positive non-treponemal test (VRDL) followed by a fluorescent treponemal antibody-absorption (FTA-Abs) test in the cerebrospinal fluid (CSF). Serum VDRL, HIV status, CSF characteristics on presentation, neuroimaging, treatment, and outcomes were registered. CSF parameters were considered abnormal when leukocyte count was above 5 cells/mm^3^, and proteins were above 40 mg/dL. In addition, in patients with HIV, we determined the most recent CD4+ cell count at neurosyphilis onset and clinical stage according to the Centers for Disease Control and Prevention (CDC) criteria. Clinical improvement was considered to have occurred when there was partial or total improvement documented by the medical staff.

The statistical analysis was performed with the SPSS software version 17. Continuous variables were compared by the Mann-Whitney or Student t test and categorical variables were analyzed by the Fisher exact test or χ^2^ test. IRB consent was obtained for performing this retrospective study.

Results {#sec1-3}
=======

The demographic and laboratory results are summarized in [Table 1](#table001){ref-type="table"}. Clinical manifestations, HIV status and neurological sequelae are shown in [Table 2](#table002){ref-type="table"}. Of the 16 patients, 14 (87%) were men.

Patients description {#sec2-1}
--------------------

Mean age at onset was 44 years old (range: 23-82). Twelve patients (75%) were HIV positive. HIV stage was B2 in 2 patients, B3 and C2 in one patient each, and C3 in 8 patients. The mean CD4^+^ cell count was 117 cells/mm^3^ (range: 3-337 cells/mm^3^). In 5 (45%) patients the diagnosis was made within the first month of HIV diagnosis. Two patients had concomitant venereal diseases (herpetic ulcers and condillomatosis), and one patient had systemic tuberculosis.

Clinical manifestations {#sec2-2}
-----------------------

Presenting symptoms were meningitis in 6 (40%), stroke in 3 (18.7%) (pons/parietal cortex), ocular manifestations in 4 (27%), and neuropsychiatric manifestations in 2 (13%). Neuropsychiatric manifestations consisted of mood irritability, alterations of judgment and behavioral changes in the first patient, while the second patient displayed visual hallucinations and memory impairment. Five additional patients had ocular involvement after a formal ophthalmologic examination. The most common ophthalmologic finding was posterior uveitis (choroiditis) in 3 cases, followed by panuveitis (2), retinitis (2), and optic neuritis in one patient. There were no cases of tabes dorsalis.

Laboratory findings {#sec2-3}
-------------------

High VRDL titers were found (serum:1:64-1:512, CSF:1:4-1:16). Mean CSF parameters were: glucose of 46 (35-77 mg/dL), proteins of 99 (36-273 mg/dL) and cells of 21.5 (5-87 cells/mm^3^).

Treatment {#sec2-4}
---------

All patients received IV Penicillin G Benzatine for 14 days. One patient presented a Jarisch-Herxheimer reaction during treatment. Five (33%) patients had neurologic sequels ([Table 2](#table002){ref-type="table"}). Clinical manifestations were earlier in patients older than 50 years old with HIV (P=0.049).

Discussion {#sec1-4}
==========

In our series, the epidemiological background is similar to the reported in the pre-HAART era. Eighty-seven percent of the patients with neurosyphilis were men, and 73% were HIV positive men. HIV diagnosis was performed within the first month of neurosyphilis onset in 5 (45%) patients, and syphilis was the clue that precluded HIV testing. As previously reported,^[@ref2]^ HIV status did not increase the incidence of late forms, nor lead to more severe or later manifestations of neurosyphilis. However, patients in C3 stage of HIV had less CSF pleocytosis (\<5 cells/mm^3^) than patients in earlier stages (P=0.018).

Accurate diagnosis of neurosyphilis is a complex task because the clinical manifestations are polymorphic, and the sensitivity and specificity of supportive laboratory tests are unclear. CSF proteins were moderately elevated in most patients, with a mean of 99 (36-273) mg/dL, as previously reported (82.8± 39.8). Pleocytosis was also moderate, 21 (5-87) cells/mm^3^, but lower to similar series (112.6±124).^[@ref2]^ However, all of our patients had a CSF-VDRL positive, while only 10 (62%) had positive serum-VDRL. CSF-VDRL is very specific, and it is considered to diagnose neurosyphilis in spite of negative serum-VDRL positivity.^[@ref2]^ Four (25%) patients had serum-VDRL titers above 1:100 (1:256-1:512). These titers suggest that most patients were in the earlier stages of infection.

Meningitis and rash consistent with secondary syphilis ([Figure 1](#fig001){ref-type="fig"}) were the most common presentation. Ocular findings were the initial manifestation of syphilis in 3 (23%) of the HIV patients and in 2 (66%) of the non-HIV patients. When patients were further tested, ocular neurosyphilis was the most common clinical presentation. Generalized panuveitis and optic neuritis were the main findings, in contrast to limited posterior uveitis found in other series.^[@ref4]^ There was a trend towards ocular involvement in HIV stage C3 patients (P=0.29). Ophthalmologic abnormalities in HIV patients are often attributed to opportunistic infections such as cytomegalovirus or toxoplasmosis, and syphilis is seldom considered. However, unlike the incidence of CMV retinitis, which decreased after HAART became available, the incidence of ocular syphilis has not decreased.^[@ref4]^ All of the patients with ocular involvement in this series had high serum VDRL titles.

The meningovascular form consist of endarteritis of vessels anywhere in the CNS resulting in stroke,^[@ref3]^ and is thought to be a late complication occurring 5 to 12 years after the initial infection with *T. Pallidum.*^[@ref3]^ It is estimated that around 3.2% and up to 15% of the patients have meningovascular manifestations at some point of the disease.^[@ref2]^ However, this was somewhat higher in this series, where stroke was present in 18%, as the initial manifestation of neurosyphilis. In the majority of cases, the middle cerebral artery is usually is affected. Surprisingly, two of the three cases with stoke in this study involved the vertebrobasilar circulation ([Figure 2](#fig002){ref-type="fig"}). Stroke of infectious etiology is often difficult to diagnose, and this finding should encourage searching for syphilis in young patients with stroke.

Recently, Mitsonis *et al.*^[@ref9]^ described a retrospective series of 81 cases with neurosyphilis. They divided the patients according to the time of presentation, where Period A corresponded to the cases diagnosed before 1984, and Period B to those between 1984 and 2005. The authors found that the former group was more likely to present with typical neurosyphilitic manifestations such as meningovascular disease, while the later group had only a few atypical symptoms plus CSF abnormalities. Interestingly, our cases were more similar to the Period A, because we found meningitis, ocular disturbances and meningovascular manifestations more often, with less frequent cognitive and psychiatric disturbances. According to the authors, the discrepancies in both groups of their study could be explained by the ongoing widespread use of antibiotics for all kind of infections. Because most cases in our series were diagnosed within the initial diagnosis of HIV and in the early stages of neurosyphilis, we assume that patients were not overtly ill before the diagnosis and therefore did not have indiscriminative use of antibiotics.

Conclusions {#sec1-5}
===========

CSF-VDRL was positive in all patients despite being positive only in 62% of the serum samples. Proteins are usually mild to moderately high, and pleocytosis can be absent in patients with neurosyphilis. When further tested, the main clinical manifestations were ophthalmologic. HIV status did not grant a worse prognosis, non-the-less, because neurosyphilis was more often in HIV patients, we consider that all patients with neurosyphilis and ophthalmologic disease should be tested for HIV.

![Secondary syphilis at neurological onset.](ni-2013-4-e19-g001){#fig001}

![Axial magnetic resonance images. A) Case 4: left hiperintense signal of the pons (DWI/FLAIR); B) Case 6: right hiperintense signal of the pons (DWI) and perimesencephalic enhacement (T1G); C) Case 15: right hyperintense signal on the parietal lobe (DWI/FLAIR).](ni-2013-4-e19-g002){#fig002}

###### 

Demographic and clinical parameters at entry.

  Parameters                   N=16
  ---------------------------- ----------------------
  Age mean (r)                 44 (23 82)
  Men                          14 (87%)
  HIV positive                 12 (75%)
  VDRL (plasma)                15 (93%) (1:4-1:512)
  Cerebrospinal fluid          
    Proteins (mg/dL)           99 (36-273)
    Cells (cells/mm^3^)        21 (5-87)
    Glucose (mg/dL)            46 (35-77)
    Positive VDRL              16 (100%)
    VRDL dilution              (1:2-1:16)
    FTA dilution               (3-4+)
  Magnetic resonance imaging   
    Meningeal enhacement       1 (6%)
    Ischemic lesions           3 (18%)

###### 

Patient characteristics, HIV status and clinical presentation.

  ID   Age   Sex   HIV (stage)   VRDL titers (plasma)   VRDL titers (CSF)   Systemic Mx   CNS Mx                                 Oftalmological finding   Outcome (live)
  ---- ----- ----- ------------- ---------------------- ------------------- ------------- -------------------------------------- ------------------------ ------------------
  1    42    M     P(C3)         1:512                  P                   Sec           Ophtalmologic                          Choroiditis              Without sequelae
  2    80    F     N             1:4                    P                                 Ophtalmologic                          Panuveitis (b)           With sequelae
  3    25    M     P(C3)         NA                     1:4                 Sec           Meningitis                             Panuveitis (b)           Without sequelae
  4    32    M     P(B3)         1:4                    P                   JHR           Meningiovasculitis (pontine stroke)    No                       Without sequelae
  5    30    M     P(C3)         1:64                   P                   Prim          Meningitis                             No                       Without sequelae
  6    29    M     P(C3)         1:64                   1:2                 Prim          Meningiovasculitis (pontine stroke)    No                       With sequelae
  7    54    F     N             NA                     1:4                 Prim          Ophtalmologic                          L Panuveitis             With sequelae
  8    48    M     N             1:4                    P                   Prim          Meningitis                             No                       Without sequelae
  9    39    M     P(C3)         1:256                  P                   Prim          Ophtalmologic                          Choroiditis (b)          Without sequelae
  10   40    M     P(C2)         1:320                  1:4                 Prim          Neuropsychiatric                       Retinitis                Without sequelae
  11   23    M     P(C3)         1:64                   1:8                 Prim          Meningitis                             Retinitis                With sequelae
  12   63    M     P(B2)         NA                     1:16                Sec           Ophtalmologic                          Panuveitis (b)           With sequelae
  13   82    M     P(C3)         NA                     1:2                 Prim          Meningitis                             Optic neuritis           With sequelae
  14   45    M     P(B2)         NA                     P                   Prim          Neuropsychiatric                       No                       Without sequelae
  15   34    M     P(C3)         NA                     P                   Prim          Meningiovasculitis (parietal stroke)   No                       Without sequelae
  16   33    M     P(B2)         1:256                  P                   Sec           Meningitis                             Retinitis                Without sequelae

P, positive; N, negative; Prim, primary; Sec, secondary; JHR, Jarisch-Herxheimer reaction; (b), bilateral, Mx, manifestations.
